The effect of written emotional disclosure on the emotional adjustment of women with breast cancer

The effect of written emotional disclosure on the emotional adjustment of women with breast cancer: A clinical trial study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250520065812N1

Enrollment

140

Registered

2025-05-29

Start date

2025-06-22

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emotional Adjustment in Women with Breast Cancer.

Interventions

Intervention 1: Intervention group: Determining and Comparing the Emotional Adjustment Scores of Women with Breast Cancer Immediately After and Two Months Following the Intervention. Intervention 2: C

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients with a clinical diagnosis of stage I to III breast cancer Willing to participate in the study Able to understand the Persian language Literate and residents of North Khorasan No history of psychiatric disorders or hospitalization in a psychiatric ward No cognitive, auditory, or speech impairments

Exclusion criteria

Exclusion criteria: History of severe head trauma, brain injury, or neuropsychiatric disorders Severe psychiatric conditions or impaired consciousness Individuals with acute complications related to surgery, chemotherapy, or radiotherapy In the event of unexpected incidents for patients in either group Patients who perform emotional disclosure through writing less than five times a week

Design outcomes

Primary

Measure	Time frame
The primary outcome variable (main variable) of the study will be emotional adjustment, which will be measured using the Rabiau questionnaire. This variable will be assessed at three stages (pre-test, post-test, and two-month follow-up), and the effect of the emotional disclosure intervention through writing will be evaluated on it. Timepoint: The time points for measuring the primary outcome in this study are:Pre-test (before the intervention begins)Post-test (one week after the intervention ends)Follow-up (two months after the intervention concludes)At all three time points, emotional adjustment will be measured using the Rabiau instrument in both the intervention and control groups. Method of measurement: Data collection in this study will be carried out using the Emotional Adaptation Scale developed by Rabio (2007).	—

Measure

Time frame

The primary outcome variable (main variable) of the study will be emotional adjustment, which will be measured using the Rabiau questionnaire. This variable will be assessed at three stages (pre-test, post-test, and two-month follow-up), and the effect of the emotional disclosure intervention through writing will be evaluated on it. Timepoint: The time points for measuring the primary outcome in this study are:Pre-test (before the intervention begins)Post-test (one week after the intervention ends)Follow-up (two months after the intervention concludes)At all three time points, emotional adjustment will be measured using the Rabiau instrument in both the intervention and control groups. Method of measurement: Data collection in this study will be carried out using the Emotional Adaptation Scale developed by Rabio (2007).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHadiseh Monadi Ziarat

Bojnourd University of Medical Sciences

hadisehmonadi19@gmail.com+98 58 3229 7096

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026